The Faseb Bioadvances is reputed journal publishes research related to Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Molecular Medicine (Q2); Physiology (Q2); Cancer Research (Q3). The ISSN of the journal is .
Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.
| Journal Title | FASEB BioAdvances |
|---|---|
| Publisher | John Wiley and Sons Inc |
| Publication Country | United Kingdom |
| ISSN | 25739832 |
| Publication Area | Biochemistry, Genetics and Molecular Biology |
| Publication Language | ENG |
| Review Process | Anonymous peer review |
| Scopus Indexed | Yes |
The Impact Factor of Faseb Bioadvances in 2026 is 2.4.
The Faseb Bioadvances is ranked in Q4.
The Faseb Bioadvances is indexed in: DOAJ, Web of Science.
There is a fee to publish in the Faseb Bioadvances. The publication fee is 3170 USD; 2890 GBP; 3540 EUR.
The journal also offers a fee waiver policy.
The Faseb Bioadvances takes an average of 10 weeks to publish research papers.
The official website of the journal is https://onlinelibrary.wiley.com/journal/25739832.
Please visit only official website of the journal to submit research papers.